Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Iguatemi (IGTI11.SA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (R$)	Price Target (R$)	Rating
2022-02-28	NaN	21.00	Buy
2022-03-31	20.45	27.00	Buy
2022-11-01	21.94	30.00	Buy
2023-01-28	19.28	28.00	Buy
2023-06-15	22.17	32.00	Buy
2023-10-23	20.00	30.00	Buy
2024-02-08	23.76	32.00	Buy
2024-07-02	20.74	30.00	Buy
2024-08-16	23.23	32.00	Buy
2025-01-13	16.65	28.00	Buy
2025-04-07	18.50	25.00	Buy

Disclosures

UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.